propafenone has been researched along with Extrasystole, Ventricular in 14 studies
Propafenone: An antiarrhythmia agent that is particularly effective in ventricular arrhythmias. It also has weak beta-blocking activity.
propafenone : An aromatic ketone that is 3-(propylamino)propane-1,2-diol in which the hydrogen of the primary hydroxy group is replaced by a 2-(3-phenylpropanoyl)phenyl group. It is a class 1C antiarrhythmic drug with local anesthetic effects, and is used as the hydrochloride salt in the management of supraventricular and ventricular arrhythmias.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To determine the effect of CYP2D6*10 genotype on propafenone pharmacodynamics in Chinese patients with ventricular arrhythmia." | 7.71 | Effect of CYP2D6*10 genotype on propafenone pharmacodynamics in Chinese patients with ventricular arrhythmia. ( Cai, WM; Chen, B; Huang, YZ; Xu, J; Zhang, FM; Zhang, YD, 2002) |
| "To determine the effect of CYP2D6*10 genotype on propafenone pharmacodynamics in Chinese patients with ventricular arrhythmia." | 3.71 | Effect of CYP2D6*10 genotype on propafenone pharmacodynamics in Chinese patients with ventricular arrhythmia. ( Cai, WM; Chen, B; Huang, YZ; Xu, J; Zhang, FM; Zhang, YD, 2002) |
| " The dosage from 50 to 100 mg/day made no difference." | 2.68 | Preliminary study of the effects of metoprolol and propafenone on ventricular arrhythmia with positive ventricular late potential. ( Duan, Y; Gao, E; Li, H; Yang, C; Zhou, Y, 1997) |
| "However, in some cases the presence of ventricular ectopic beats indicates susceptibility towards life-threatening arrhythmias or ventricular dysfunction." | 2.46 | [When and how to treat ventricular ectopic beats]. ( D'Este, D; Sorbo, MD, 2010) |
| "Flecainide was the most effective AAD in the achievement of complete/near complete or significant PVC burden reduction, compared to propafenone and sotalol." | 1.91 | Idiopathic premature ventricular complexes treatment: Comparison of flecainide, propafenone, and sotalol. ( Bukumirić, Z; Jurčević, R; Kojić, D; Marić, M; Radunović, A; Rajsic, S; Sušić, M; Tomović, M; Žugić, V, 2023) |
| "A coincidence between intermittent esophageal dysphagia and cardiac arrhythmia, frequent premature ventricular complexes (PVC) were confirmed by clinical observation, simultaneous ECG monitoring, and motility study." | 1.36 | High-resolution esophageal manometry with ECG monitoring for management of premature ventricular complexes-associated dysphagia. ( Kalin, K; Kulakowski, P; Sikora, K; Stec, S; Tarnowski, W, 2010) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (21.43) | 18.2507 |
| 2000's | 2 (14.29) | 29.6817 |
| 2010's | 8 (57.14) | 24.3611 |
| 2020's | 1 (7.14) | 2.80 |
| Authors | Studies |
|---|---|
| Kojić, D | 1 |
| Radunović, A | 1 |
| Bukumirić, Z | 1 |
| Rajsic, S | 1 |
| Sušić, M | 1 |
| Marić, M | 1 |
| Žugić, V | 1 |
| Jurčević, R | 1 |
| Tomović, M | 1 |
| Hyman, MC | 1 |
| Mustin, D | 1 |
| Supple, G | 1 |
| Schaller, RD | 1 |
| Santangeli, P | 1 |
| Arkles, J | 1 |
| Lin, D | 1 |
| Muser, D | 1 |
| Dixit, S | 1 |
| Nazarian, S | 1 |
| Epstein, AE | 1 |
| Callans, DJ | 1 |
| Marchlinski, FE | 1 |
| Frankel, DS | 2 |
| Capucci, A | 1 |
| Ciliberti, G | 1 |
| Guerra, F | 1 |
| Stec, S | 2 |
| Tarnowski, W | 1 |
| Kalin, K | 1 |
| Sikora, K | 1 |
| Kulakowski, P | 1 |
| D'Este, D | 1 |
| Sorbo, MD | 1 |
| Hasdemir, C | 1 |
| Musayev, O | 1 |
| Kehribar, DY | 1 |
| Kartal, Y | 1 |
| Can, LH | 1 |
| Pytkowski, M | 1 |
| Sikorska, A | 1 |
| Zaborska, B | 1 |
| Kryński, T | 1 |
| Szymot, J | 1 |
| Kułakowski, P | 1 |
| Cai, WM | 1 |
| Xu, J | 1 |
| Chen, B | 1 |
| Zhang, FM | 1 |
| Huang, YZ | 1 |
| Zhang, YD | 1 |
| Mondillo, S | 1 |
| Faglia, S | 1 |
| D'Aprile, N | 1 |
| Mangiacotti, L | 1 |
| Campolo, MA | 1 |
| Agricola, E | 1 |
| Palazzuoli, V | 1 |
| Gao, E | 1 |
| Yang, C | 1 |
| Li, H | 1 |
| Duan, Y | 1 |
| Zhou, Y | 1 |
| Wang, X | 1 |
| Zhang, J | 1 |
| Shi, D | 1 |
| Zhou, G | 1 |
| Saikawa, T | 1 |
| Niwa, H | 1 |
| Ito, M | 1 |
| Ishida, S | 1 |
| Nakagawa, M | 1 |
| Maeda, T | 1 |
| Takeshita, Y | 1 |
| Takakura, T | 1 |
| Sakata, T | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Bipolar Radio-frequency Ablation After Standard Unipolar Approach for Ventricular Arrhythmias Originating From the Base of the Heart. The BiUniVA Prospective Registry[NCT05707637] | 100 participants (Anticipated) | Observational [Patient Registry] | 2022-11-02 | Recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 review available for propafenone and Extrasystole, Ventricular
| Article | Year |
|---|---|
[When and how to treat ventricular ectopic beats].
Topics: Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Electrocardiography; Encainide; Exercise Test; Humans; | 2010 |
5 trials available for propafenone and Extrasystole, Ventricular
| Article | Year |
|---|---|
Benign symptomatic premature ventricular complexes: short- and long-term efficacy of antiarrhythmic drugs and radiofrequency ablation.
Topics: Adolescent; Adult; Aged; Analysis of Variance; Anti-Arrhythmia Agents; Catheter Ablation; Cross-Over | 2012 |
[Therapy of arrhythmia induced by myocardial ischemia. Association of L-carnitine, propafenone and mexiletine].
Topics: Aged; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cardiac Complexes, Premature; Carnitine; Drug Sy | 1995 |
Preliminary study of the effects of metoprolol and propafenone on ventricular arrhythmia with positive ventricular late potential.
Topics: Adult; Anti-Arrhythmia Agents; Electrocardiography; Female; Humans; Male; Metoprolol; Middle Aged; P | 1997 |
Clinical observation on 84 cases of ventricular premature beat with deficiency syndrome treated by qi lu tang.
Topics: Adult; Aged; Anti-Arrhythmia Agents; Coronary Disease; Drugs, Chinese Herbal; Female; Humans; Male; | 1998 |
The effect of propafenone on premature ventricular contractions (PVC): an analysis based on heart rate dependency of PVCs.
Topics: Aged; Anti-Arrhythmia Agents; Electrocardiography, Ambulatory; Electrophysiology; Female; Heart Rate | 2001 |
8 other studies available for propafenone and Extrasystole, Ventricular
| Article | Year |
|---|---|
Idiopathic premature ventricular complexes treatment: Comparison of flecainide, propafenone, and sotalol.
Topics: Anti-Arrhythmia Agents; Electrocardiography; Flecainide; Humans; Propafenone; Retrospective Studies; | 2023 |
Class IC antiarrhythmic drugs for suspected premature ventricular contraction-induced cardiomyopathy.
Topics: Anti-Arrhythmia Agents; Cardiomyopathies; Echocardiography; Electrocardiography; Female; Flecainide; | 2018 |
Reply to the Editor- Flecainide and Propafenone: Good twins for premature ventricular contractions' killing but not exactly superimposable.
Topics: Anti-Arrhythmia Agents; Electrocardiography; Flecainide; Humans; Propafenone; Ventricular Premature | 2018 |
To the Editor- Flecainide and propafenone: Good twins for premature ventricular contractions' killing but not exactly superimposable.
Topics: Anti-Arrhythmia Agents; Cardiomyopathies; Flecainide; Humans; Propafenone; Ventricular Premature Com | 2018 |
High-resolution esophageal manometry with ECG monitoring for management of premature ventricular complexes-associated dysphagia.
Topics: Anti-Arrhythmia Agents; Deglutition Disorders; Drug Monitoring; Electrocardiography; Female; Humans; | 2010 |
Chronic cough and tachycardia-induced cardiomyopathy in a patient with idiopathic frequent, monomorphic premature ventricular contractions.
Topics: Aged; Anti-Arrhythmia Agents; Cardiomyopathies; Chronic Disease; Cough; Female; Humans; Propafenone; | 2013 |
[Not so simple procedure in "simple" arrhythmias of ventricular].
Topics: Anti-Arrhythmia Agents; Catheter Ablation; Female; Humans; Male; Metoprolol; Propafenone; Ventricula | 2012 |
Effect of CYP2D6*10 genotype on propafenone pharmacodynamics in Chinese patients with ventricular arrhythmia.
Topics: Adult; Aged; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cytochrome P-450 CYP2D6; Female; Genotype | 2002 |